vaccine experts will meet today to consider Pfizer’s vaccine, and again on Dec. 17 for Moderna’s. The Vaccines and Related Biological Products Advisory Committee, made up of independent vaccine experts, infectious disease specialists, industry representatives and a consumer representative, will pick apart Pfizer’s data for any red flags.
They will debate whether the shot is safe and effective enough to be cleared for emergency use.Then, they will vote. That vote could come as early as Thursday afternoon.